CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 


Moderna Inc 's Operating Profit Margin by quarter

Trends, Rankings, Statistics



MRNA Operating Profit Margin (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Revenue Change 6462.07 % 22989.76 % 431893.13 % 309527.45 % 100431.82 %
Seq. Revenue Change 124.78 % 239.38 % 261.44 % 137.99 % 690.93 %
Revenue In Millions $4,354.00 $1,937.00 $570.75 $157.91 $66.35
Operating Profit Margin 70.33 % 65.36 % - - -
Operating Profit Margin Total Ranking # 122 # 138 # # #
Operating Income In Millions $3,062.00 $1,266.00 $-275.04 $-235.12 $-122.13
Y / Y Operating Income Change - - - - -
Seq. Operating Income Change 141.86 % - - - -


Commenting Second Quarter 2021 Operating Profit Margin
Moderna Inc Operating Income grew by 141.86 % in II. Quarter sequntially to 3,062 millions, while Revenue increased by 124.78 %, this led to improvement in Company's Operating Profit Margin to 70.33 %, above Moderna Inc average Operating Profit Margin.

Observing second quarter 2021 results within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher Operating Profit Margin. While Operating Profit Margin total ranking has impoved so far to 122, from total ranking in previous quarter at 138.
Explain Operating Margin
MRNA's Operating Profit Margin second quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 14
Overall # 122

Operating Profit Margin Statistics
High Average Low
73 % 45.3 % 2.3 %
(Dec 31 2014)   (Dec 31 2013)




Other Operating Profit Margin Profitability Ratios
MRNA's Cumulative Operating Profit Margin
Biotechnology & Pharmaceuticals Industry Operating Profit Margin Trends and Statistics
Healthcare Sector Operating Profit Margin Statistics
Operating Profit Margin Profitability Trends for overall market
MRNA's Operating Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Profit Margin
Lowest Ranking Operating Profit Margin
Operating Profit Margin Profit Margin for MRNA's Competitors
Operating Profit Margin Profit Margin for Moderna Inc 's Suppliers
Operating Profit Margin Profit Margin for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Operating Income Growth
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons


Companies with similar Operating Profit Margin in the quarter ending Jun 30 2021, within Biotechnology & Pharmaceuticals Industry Operating Profit MarginJun 30 2021 MRQ Operating IncomeJun 30 2021 MRQ Revenue
Royalty Pharma Plc  134.23 %$ 744.949 $ 554.963 
Crispr Therapeutics Ag  84.67 %$ 762.618 $ 900.701 
Moderna Inc   70.33 %$ 3,062.000 $ 4,354.000 
Halozyme Therapeutics Inc   68.19 %$ 93.047 $ 136.455 
Fulgent Genetics Inc   64.38 %$ 98.898 $ 153.616 
Skinvisible Inc   55.56 %$ 0.160 $ 0.287 
Gilead Sciences Inc   36.13 %$ 2,246.000 $ 6,217.000 
Vir Biotechnology Inc   34.46 %$ 61.017 $ 177.068 
Tarsus Pharmaceuticals Inc   33.07 %$ 7.282 $ 22.017 
Cidara Therapeutics Inc   32.78 %$ 10.773 $ 32.863 
Abbvie Inc   31.81 %$ 4,441.000 $ 13,959.000 
Repligen Corp  29.60 %$ 48.240 $ 162.960 
Bio techne Corp  26.48 %$ 68.583 $ 259.028 
La Jolla Pharmaceutical Company  23.62 %$ 3.793 $ 16.059 
Neurocrine Biosciences Inc   21.74 %$ 62.800 $ 288.900 
Biogen Inc   17.50 %$ 485.700 $ 2,775.000 
Twinlab Consolidated Holdings Inc   15.39 %$ 2.787 $ 18.109 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TREB's Profile

Stock Price

TREB's Financials

Business Description

Fundamentals

Charts & Quotes

TREB's News

Suppliers

TREB's Competitors

Customers & Markets

Economic Indicators

TREB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071